Kısa ve uzun süreli metformin kullanımında yorgunluk, ruhsal iyilik hali ve taşikardinin incelenmesi

Year 2025, Volume: 50 Issue: 1, 90 - 98, 31.03.2025

Zahide Akeren

https://doi.org/10.17826/cumj.1589276

Abstract

Amaç: Çalışmada kısa ve uzun süreli metformin kullanıcılarının bazı sosyo-demografik özelliklerine göre karşılaştırılması ve yorgunluk, taşikardi ve ruhsal iyilik hali arasındaki ilişkilerin incelenmesi amaçlandı.
Gereç ve Yöntem: Kesitsel tarama tasarımlı çalışmada, 46'sı kısa süreli, 46'sı uzun süreli metformin kullanıcısı olmak üzere 92 hastaya ulaşıldı. Yorgunluk, Kronik Hastalık Tedavi-Yorgunluk Fonksiyonel Değerlendirmesi Ölçeği (FACIT-F), taşikardi saturasyon cihazı, iyilik hali Dünya Sağlık Örgütü İyilik Hali İndeksi (WHO-5) ile ölçüldü.
Bulgular: Kısa süreli metformin kullanan grupta ortalamalar; metformin kullanım yılı 1,82±0,77, nabız 82,48±8,80, FACIT-F skoru 20,37±7,25, WHO-5 skoru 15,70±3,23 olarak bulundu. Uzun süreli metformin kullanan grupta ortalamalar; metformin kullanım yılı 5,93±2,68, nabız 84,57±9,64, FACIT-F skoru 25,33±5,65, WHO-5 skoru 12,63±3,70 olarak bulundu. İyilik hali diyabet yılı, metformin kullanım yılı, nabız hızı ve yorgunlukla negatif korelasyon göstermektedir. FACIT-F, metformin yılı ve nabız hızı iyilik halinin toplam %41,9'unu açıklıyor. FACIT-F'nin (β=-.51, t=-5.82, p= .000) ve metformin kullanım yılının (β=-.19, t=-2.12, p= .037) iyilik halini önemli ölçüde azalttığı, nabız hızının ise iyilik halinde önemli bir etkiye sahip olmadığı görüldü.
Sonuç: Metforminin uzun süreli kullanımının yorgunluğa ve olumsuz psikolojik iyilik haline neden olduğu bulunmuştur. Yorgunluk, metformin kullanım yılı ve nabız sayısı metformin kullanan Tip II diyabet hastalarında ruhsal iyi oluşun önemli belirleyicileridir.

Keywords

Metformin, Ruhsal Iyi Oluş, Yorgunluk, Taşikardi.

Investigation of fatigue, mental well-being and tachycardia in short- and long-term metformin use

Abstract

Purpose: The current study aimed compare short and long-term metformin users according to socio-demographic characteristics and to examine the relationships between fatigue, tachycardia and psychological well-being.
Materials and Methods: In cross-sectional study were reached 92 patients, 46 short-term and 46 long-term metformin users. It was measured fatigue with the Functional Assessment of Chronic Illness Treatment-Fatigue Scale (FACIT-F), tachycardia with saturation device, well-being with the World Health Organization Well-Being Index (WHO-5).
Results: For the group using short-term metformin, the mean; year of metformin use was 1.82±0.77 and pulse rate was 82.48±8.80, FACIT-F score was 20.37±7.25, and WHO-5 score was 15.70±3.23. The group using long-term metformin mean year of metformin use was 5.93±2.68, pulse rate was 84.57±9.64, FACIT-F score was 25.33±5.65 and WHO-5 score was 12.63±3.70. Well-being is negatively correlated with the year of diabetes, year of metformin use, pulse rate and fatigue. FACIT-F, metformin year and pulse rate explain a total of 41.9% of the variance in well-being. FACIT-F (β=-.51, t=-5.82, p= .000) and the year of metformin use (β=-.19, t=-2.12, p= .037) significantly decrease well-being, while pulse rate does not have a significant effect on well-being.
Conclusions: Long-term use of metformin has been found cause fatigue and negative psychological well-being. Fatigue, year of metformin use and pulse rate number are important predictors of psychological well-being in Type II diabetes patients using metformin.

Keywords

Metformin, Mental Well-Being, Fatigue, Tachycardia

References

• Almatrafi SB, Bakr ES, Almatrafi AA, Altayeb MM. Prevalence of vitamin B12 deficiency and its association with metformin-treated type 2 diabetic patients: A cross sectional study. Hum Nutr Metab. 2022;27:200138.
• Seo-Mayer PW, Thulin G, Zhang L, Alves DS, Ardito T, Kashgarian M et al. Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia. Am J Physiol-Ren Physiol. 2011;301:1346-57.
• Triggle CR, Mohammed I, Bshesh K, Marei I, Ye K, Ding H et al. Metformin: Is it a drug for all reasons and diseases?. Metabolism. 2022;133:155223.
• Polat HB, Ayaz T. Metformin kullanan tip 2 diyabetli bireylerde B12 vitamin eksikliğinin belirlenmesi. Turk Klin J Health Sci. 2019;4:237-41.
• Tomkin GH, Hadden DR, Weaver JA, Montgomery, D. Vitamin-B12 status of patients on long-term metformin therapy. Br Med J. 1971;2:685-7.
• Ko SH, Ko SH, Ahn YB, Song KH, Han KD, Park Y et al. Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes. J. Korean Med Sci. 2014;29:965-72.
• Kim J, Ahn CW, Fang S, Lee HS, Park JS. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine. 2019;98:e17918.
• Torrez M, Chabot‐Richards D, Babu D, Lockhart E, Foucar K. How I investigate acquired megaloblastic anemia. Int J Lab Hematol. 2022;44:236-47.
• Obeagu EI, Babar Q, Obeagu GU. Megaloblastic anaemia-a review. Int J Curr Res Med Sci. 2021;7:17-24.
• Green R, Allen LH, Bjorke-Monsen AL, Brito A, Guéant JL, Miller J et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:1-20.
• Thakkar K, Billa G. Treatment of vitamin B12 deficiency–methylcobalamine? cyancobalamine? hydroxocobalamin?-clearing the confusion. Eur J Clin Nutr. 2015;69:1-2.
• Bell DS. Metformin‐induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes. Diabetes Obes Metab. 2022;24:1423-8.
• Berchtold P, Bolli P, Arbenz U, Keiser G. Disturbance of intestinal absorption following metformin therapy observations on the mode of action of biguanides. Diabetologia. 1969;5:405-12.
• Mazokopakis EE, Starakis IK. Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract. 2012;97:359-67.
• Devalia V, Hamilton MS, Molloy AM, British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166:496-513.
• Quadros EV. Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol. 2010;148:195-204.
• Freeman AM, Rai M, Morando DW. Anemia screening. StatPearls, Treasure Island, 2023.
• Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care. 2013;36:2981-7.
• Biemans E, Hart HE, Rutten GE, Cuellar Renteria VG, Kooijman-Buiting AM, Beulens JW. Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin. Acta Diabetol. 2015;52:383-93.
• Obeid R, Heil SG, Verhoeven MM, Van den Heuvel EG, De Groot LC, Eussen SJ. Vitamin B12 intake from animal foods, biomarkers, and health aspects. Front Nutr. 2019;6:93.
• Gürer B. Evaluation of the supply and demand for animal products in terms of sufficient and balanced nutrition in Turkey. J Food. 2021;46:1450-66.
• Watanabe F, Bito T. Vitamin B12 sources and microbial interaction. Exp Biol Med. 2018;243:148-58.
• Cohen L, Manion L, Morrison K. Research methods in education. Routledge, London. 2018.
• DeFronzo RA, Goodman AM, Multicenter Metformin SG. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:541-9.
• Reinstatler L, Qi YP, Williamson RS, Oakley GP. Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: the National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care. 2012;35:327-33.
• Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. In Semin Hematol. 1997;34:13-9.
• Çinar D, Yava A. Validity and reliability of functional assessment of chronic illness treatment-fatigue scale in Turkish patients with type 2 diabetes. Endocrinol Diabetes Nutr. 2018;65:409-17.
• Eser E, Cevik C, Baydur H, Güneş S, Esgin TA, Öztekin ÇS. Reliability and validity of the Turkish version of the WHO-5, in adults and older adults for its use in primary care settings. Prim Health Care Res Dev. 2019;20:e100.
• Tabachnick BG, Fidell LS. Using multivariate statistics. Pearson, Boston. 2013.
• Douek IF, Allen SE, Ewings P, Gale E, Bingley PJ, Metformin Trial Group. Continuing metformin when starting insulin in patients with type 2 diabetes: a double‐blind randomized placebo‐controlled trial. Diabet Med. 2005;22:634-40.
• Sommerfeldt SL, Schaefer SM, Brauer M, Ryff CD, Davidson RJ. Individual differences in the association between subjective stress and heart rate are related to psychological and physical well-being. Psychol Sci. 2019;30:1016-29.
• Gonzalez-Carrasco M, Casas F, Malo S, Viñas F, Dinisman T. Changes with age in subjective well-being through the adolescent years: Differences by gender. J Happiness Stud. 2017;18:63-88.
• Katsaros T, Filioussi K, Bonovas S. Should we screen diabetic patients using biguanides for megaloblastic anaemia?. Aust Fam Physician. 2003;32:383–4.
• Ting RZW, Szeto CC, Chan MHM, Ma KK, Chow KM. Risk factors of vitamin B12 deficiency in patients receiving metformin. Arch Intern Med. 2006;166:1975-9.
• Fritschi C, Quinn L. Fatigue in patients with diabetes: a review. J Psychosom Res. 2010;69:33-41.
• Jafari N, Farajzadegan Z, Loghmani A, Majlesi M, Jafari N. Spiritual well‐being and quality of life of Iranian adults with type 2 diabetes. Evidence‐Based Complement Altern Med. 2014;2014:619028.
• Robinson DJ, O'luanaigh C, Tehee E, O'connell H, Hamilton F, Chin AV et al. Associations between holotranscobalamin, vitamin B12, homocysteine and depressive symptoms in community‐dwelling elders. Int J Geriatr Psychiatry.2011;26:307-13.
• Sonmez B, Kasım I. Anxiety, depression and quality of life among the patients with diabetes mellitus. Turk J Fam Pract. 2013;17:119-24.
• Seo YM, Hahm JR, Kim TK, Choi WH. Factors affecting fatigue in patients with type II diabetes mellitus in Korea. Asian Nurs. Res. 2015;9:60-4.
• Jain A, Sharma R, Choudhary PK, Yadav N, Jain G, Maanju M. Study of fatigue, depression, and associated factors in type 2 diabetes mellitus in industrial workers. Ind Psychiatry J. 2015;24:179-84.